Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

BACKGROUND: Despite some successes with checkpoint inhibitors for treating cancer, most patients remain refractory to treatment, possibly due to the inhibitory nature of the tumor stroma that impedes the function and entry of effector cells. We devised a new technique of combining immunotherapy with...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Immunother Cancer
मुख्य लेखकों: Barsoumian, Hampartsoum B, Ramapriyan, Rishab, Younes, Ahmed I, Caetano, Mauricio S, Menon, Hari, Comeaux, Nathan I, Cushman, Taylor R, Schoenhals, Jonathan E, Cadena, Alexandra P, Reilly, Timothy P, Chen, Dawei, Masrorpour, Fatemeh, Li, Ailin, Hong, David S, Diab, Adi, Nguyen, Quynh-Nhu, Glitza, Isabella, Ferrarotto, Renata, Chun, Stephen G, Cortez, Maria Angelica, Welsh, James
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMJ Publishing Group 2020
विषय:
Clinical/Translational Cancer Immunotherapy
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7592253/
https://ncbi.nlm.nih.gov/pubmed/33106386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000537
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन